Evonik Industries' stock has dropped 15%, prompting a study of its financials. Focus is on ROE, a measure of profitability and ability to generate returns. Evonik's ROE of 2.7% is below industry average, impacting its net income decline.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing